MThera Pharma

MThera Pharma is a biopharmaceutical company that develops first-class botanical drug products using novel, multi-component/multi-target driven disease-modifying therapies to address multiple etiologies and treat chronic and complex conditions such as Parkinson's disease, dementia, and inflammatory bowel disease. MThera's platform technology, SyMthomics, consists of its MThera-CODA system (an AI-based computer system), cutting-edge multi-omics integration technology, and systems biology and bioinformatics.